Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
GeoVax Advances GEO-MVA to Strengthen U.S. and Global Readiness. ATLANTA, GA - February 19, 2025 (NEWMEDIAWIRE) - The confirmation of a fourth case of Clade 1 Mpox in New York und ...
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
GeoVax's Vaccine Development Programs Align with Anticipated HHS Focus on Vaccine Safety, Diversification and Domestic ...